Mao L, Fang M, Chen Y, Wei X, et al. Atezolizumab Plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: a Multicenter, Open-label, Single-arm Phase 2 Study. Clin Cancer Res 2022 Aug 31. pii: 708943. doi: 10.1158/1078-0432.CCR-22-1528.
PMID: 36044526